NeuroSense Therapeutics Ltd. Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019
NeuroSense Therapeutics Ltd. (NRSN) reported Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 of $2.09 per share for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 · last filed 2024-04-04
| Period end | Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2023-12-31 | $2.09 20-F · filed 2024-04-04 |
| 2022-12-31 | $1.26 20-F · filed 2024-04-04 |